Progressive Care Announces Annual Audited 2020 Report Earnings Call and Business Update on April 1st, 2021
29 March 2021 - 10:43PM
InvestorsHub NewsWire
MIAMI, FL -- March 29, 2021 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care,” the “Company,” “we,” “our”), is
pleased to announce that the Company has scheduled an investor
conference call at 4:30 PM ET on Thursday, April 1st, 2021.
“We are looking forward to reporting our 2020 audited financials
and updating our shareholders on our current and future initiatives
and plans,” stated Chairman and CEO Alan Jay Weisberg.
In addition, interested parties have the opportunity to submit
questions concerning the Company prior to the call to Stuart Smith
at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by
12:00 PM EST on Thursday, April 1st, 2021. Mr. Smith will compile a
list of questions and submit them to the Company prior to the
conference call. Which questions will be addressed will be based on
the relevance to the shareholder base, and the question’s
appropriateness in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a
replay will be available at https://www.smallcapvoice.com/clients/rxmd/. shortly
after the call has concluded.
An archived version of the webcast will also be
available https://progressivecareus.com/news/.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management. Cautionary
Statement Regarding Forward-Looking Statements Statements contained
herein that are not based upon current or historical fact are
forward-looking in nature and constitute forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such
forward-looking statements reflect the Company’s expectations about
its future operating results, performance, and opportunities that
involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
“anticipate,” “believe,” “estimate,”“upcoming,” “plan,” “target,”
“intend” and “expect” and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company’s
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
For SmallCapVoice.com, Inc.
Stuart T. Smith
512-267-2430
ssmith@smallcapvoice.com
www.SmallCapVoice.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2024 to May 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From May 2023 to May 2024